{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:27:44Z","timestamp":1789165664038,"version":"build-2803163510"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:sec id=\"ab-soi240105-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Tumor deposits have prognostic value in colon cancer, but the current American Joint Committee on Cancer (AJCC) staging only considers them if there are no concurrent positive lymph nodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi240105-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To devise a staging system for colon cancer by integrating counts of tumor deposits with positive lymph nodes while retaining the current AJCC staging framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi240105-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study examines data from a large-volume, tertiary care center database (January 2010 through March 2023 with follow-up until December 2023) and the population-based National Cancer Database (January 2010 through December 2020 with follow-up until December 2021). Participants were adults (age 18-75 years) with stage III colon adenocarcinoma who underwent chemotherapy, and had a specified positive lymph node count and tumor deposit count were selected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi240105-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>A real positive lymph nodes count was developed and used to derive Sassun-Mayo N\/tumor, lymph node, and metastasis (TNM) stages that were compared with the AJCC N\/TNM stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi240105-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Receiver operating characteristic (ROC) curves and Kaplan-Meier analyses for 3-year overall survival were performed to assess the efficiency of the 2 staging systems. The concordance index was used for validation using the National Cancer Database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi240105-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From a total patient number of 11\u202f162 (institutional) and 848\u202f704 (national), the final patient numbers were 788 and 77\u202f790, respectively. The institutional database patients had a mean (SD) age of 58.5 (11.5) years; there were 433 male patients (54.9%) and 355 female (45.1%). The national database patients had a mean (SD) age of 59.3 (10.6) years; there were 40\u202f315 male patients (51.8%) and 37\u202f475 female (48.2%). ROC curve areas were improved using the Sassun-Mayo stages (3-year death for AJCC TMN, 0.63 [95% CI, 0.57-0.69] vs 0.66 [95% CI, for 0.60-0.72] for Sassun-Mayo TNM). Kaplan-Meier curves revealed visible overlaps among AJCC N stages, which were absent in the Sassun-Mayo N stages. The concordance index in the Sassun-Mayo N\/TNM stages was 0.611 and 0.616, respectively, while in the AJCC N\/TNM stages, it was 0.598 and 0.606, respectively. Patients upstaged from N1 to N2 (n\u2009=\u200910\u202f307; 13.2%) had a 3-year overall survival rate nearly identical to that of AJCC N2a patients. Additionally, 3001 patients (3.9%) were upstaged from N2a to N2b, indicating that 13\u202f308 patients (17.1%) with stage III colon cancer across cohorts were understaged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi240105-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study found that Sassun-Mayo N\/TNM staging provided superior overall survival stratification compared with the current AJCC staging, suggesting that their implementation could improve prognostication in colon cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2024.6729","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T11:00:55Z","timestamp":1738753255000},"page":"408","source":"Crossref","is-referenced-by-count":24,"title":["Validated Integration of Tumor Deposits in N Staging for Prognostication in Colon Cancer"],"prefix":"10.1001","volume":"160","author":[{"given":"Richard","family":"Sassun","sequence":"first","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaclara","family":"Sileo","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyi Cheng","family":"Ng","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Violante","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Gomaa","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Mandrekar","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen K.","family":"Rumer","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"McKenna","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Larson","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"soi240105r1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1200\/JCO.2016.68.9091","article-title":"Tumor deposits in colorectal cancer: improving the value of modern staging, a systematic review and meta-analysis.","volume":"35","author":"Nagtegaal","year":"2017","journal-title":"J Clin Oncol"},{"key":"soi240105r2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jss.2019.07.099","article-title":"Prognostic significance of tumor deposits in patients with stage III colon cancer: a nomogram study.","volume":"245","author":"Zheng","year":"2020","journal-title":"J Surg Res"},{"issue":"2","key":"soi240105r3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ags3.12652","article-title":"Tumor deposits in colorectal cancer: refining their definition in the TNM system.","volume":"7","author":"Ueno","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"issue":"9","key":"soi240105r4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/DCR.0000000000001152","article-title":"Impact of tumor deposits on oncologic outcomes in stage III colon cancer.","volume":"61","author":"Wong-Chong","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"soi240105r5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.annonc.2021.07.009","article-title":"Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB\/SWOG 80702 phase III study (Alliance).","volume":"32","author":"Cohen","year":"2021","journal-title":"Ann Oncol"},{"issue":"9","key":"soi240105r6","doi-asserted-by":"publisher","first-page":"O248","DOI":"10.1111\/codi.14289","article-title":"Prognostic value and characteristics of N1c colorectal cancer.","volume":"20","author":"Bouquot","year":"2018","journal-title":"Colorectal Dis"},{"issue":"6","key":"soi240105r7","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad122","article-title":"Tumour deposits in colon cancer predict recurrence and reduced survival in a nationwide population-based study.","volume":"7","author":"J\u00f6rgren","year":"2023","journal-title":"BJS Open"},{"issue":"4","key":"soi240105r8","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3390\/ijms24043573","article-title":"New histoprognostic factors to consider for the staging of colon cancers: tumor deposits, invasive tumor infiltration and high-grade budding.","volume":"24","author":"Riffet","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"soi240105r9","doi-asserted-by":"publisher","first-page":"16909","DOI":"10.1038\/s41598-022-21331-z","article-title":"Identifying the long-term survival beneficiary of chemotherapy for stage N1c sigmoid colon cancer.","volume":"12","author":"Liu","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"soi240105r10","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/cam4.2034","article-title":"Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy.","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"},{"issue":"6","key":"soi240105r11","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC 8th edition: colorectal cancer.","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"soi240105r12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.916091","article-title":"The prognostic value of adjuvant chemotherapy in colon cancer with solitary tumor deposit.","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"soi240105r13","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines.","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"23","key":"soi240105r14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.21037\/atm.2019.11.69","article-title":"The unique prognostic characteristics of tumor deposits in colorectal cancer patients.","volume":"7","author":"Liu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"3","key":"soi240105r15","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/cam4.5099","article-title":"The new \u2018coN\u2019 staging system combining lymph node metastasis and tumour deposit provides a more accurate prognosis for TNM stage III colon cancer.","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med"},{"issue":"15","key":"soi240105r16","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, International Duration Evaluation of Adjuvant (IDEA) France, phase III trial.","volume":"36","author":"Andr\u00e9","year":"2018","journal-title":"J Clin Oncol"},{"issue":"16","key":"soi240105r17","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1200\/JCO.19.00281","article-title":"Duration of oxaliplatin-containing adjuvant therapy for stage III colon cancer: ASCO clinical practice guideline.","volume":"37","author":"Lieu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10","key":"soi240105r18","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"soi240105r19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"soi240105r20","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/SLA.0000000000005355","article-title":"Revised nodal staging integrating tumor deposit counts with positive lymph nodes in patients with stage III colon cancer.","volume":"277","author":"Pyo","year":"2023","journal-title":"Ann Surg"},{"key":"soi240105r21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.548692","article-title":"A modified pathological N stage including status of tumor deposits in colorectal cancer with nodal metastasis.","volume":"10","author":"Pei","year":"2020","journal-title":"Front Oncol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2829924\/jamasurgery_sassun_2025_oi_240105_1745003758.89205.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:00:27Z","timestamp":1745406027000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2829924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2024.6729","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}